Center-Authored Papers

Filters: Author is Martins, Renato G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA et al..  2008.  Non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):228-69.
Bauman JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE.  2008.  Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.. The Annals of thoracic surgery. 86(5):1632-8;discussion1638-9. Abstract
Kalemkerian GP, Akerley W, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Johnson BE, Kessinger A, Koczywas M et al..  2008.  Small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):294-314.
Till BG, Martins RG.  2008.  Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.. Head & neck. 30(6):810-4. Abstract
Ramsey SD, Martins RG, Blough DK, Tock LS, Lubeck D, Reyes CM.  2008.  Second-line and third-line chemotherapy for lung cancer: use and cost.. The American journal of managed care. 14(5):297-306. Abstract
2010
Eaton KD, Martins RG.  2010.  Maintenance chemotherapy in non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(7):815-21. Abstract
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
2011
Hirsch FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
2012
Martins RG, D'Amico TA, Loo BW, Pinder-Schenck M, Borghaei H, Chaft JE, Ganti AKP, Kong F-MS, Kris MG, Lennes IT et al..  2012.  The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(5):599-613. Abstract
2013
Martins RG, Parvathaneni U, Bauman JE, Sharma AK, Raez LE, Papagikos MA, Yunus F, Kurland BF, Eaton KD, Liao JJ et al..  2013.  Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(11):1415-21. Abstract
Adult
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
Bauman JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE.  2008.  Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.. The Annals of thoracic surgery. 86(5):1632-8;discussion1638-9. Abstract
Aged
Bauman JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE.  2008.  Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.. The Annals of thoracic surgery. 86(5):1632-8;discussion1638-9. Abstract
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
Antineoplastic Agents
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
Ramsey SD, Martins RG, Blough DK, Tock LS, Lubeck D, Reyes CM.  2008.  Second-line and third-line chemotherapy for lung cancer: use and cost.. The American journal of managed care. 14(5):297-306. Abstract
Antineoplastic Agents, Phytogenic
Till BG, Martins RG.  2008.  Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.. Head & neck. 30(6):810-4. Abstract
Antineoplastic Combined Chemotherapy Protocols
Hirsch FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
Ramsey SD, Martins RG, Blough DK, Tock LS, Lubeck D, Reyes CM.  2008.  Second-line and third-line chemotherapy for lung cancer: use and cost.. The American journal of managed care. 14(5):297-306. Abstract
Biomarkers, Pharmacological
Hirsch FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
Cadherins
Hirsch FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
Carboplatin
Hirsch FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
CARCINOMA
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
Carcinoma, Adenoid Cystic
Till BG, Martins RG.  2008.  Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.. Head & neck. 30(6):810-4. Abstract
Carcinoma, Medullary
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract